In this manuscript, we also observed the similar phenomena that iCAFs could essentially exclude CD8 + cells infiltrating into the tumor cells, highlighting the immune-modulating function of iCAFs in BLCA. The gene discussed is CD8A; the disease is bladder transitional cell carcinoma.